Survey Name: cHeCKD from physician perspective (correlation between hyperuricemia and CKD) from physician perspective
Subject: Participation in study entitled: Understanding diagnosis and management of Hyperuricemia associated with CKD from Physicians perspective
Hyperuricemia is common in chronic kidney disease (CKD) and may be present in 50% of patients presenting for dialysis. Relationship of serum uric acid (UA) with CKD is not linear. CKD leads to hyperuricemia due to decreased urinary excretion of UA while hyperuricemia may also induce kidney dysfunction and contribute to CKD progression through a number of potential mechanisms. This may occur in part because conditions such as obesity, diabetes, metabolic syndrome, and hypertension are risk factors for CKD and are also commonly associated with hyperuricemia. It is possible that controlling hyperuricemia, especially if achieved early, may reduce kidney disease risk.
Management of hyperuricemia can be challenging because of cautions or contraindications in those with diminished kidney function as well as other common comorbidities that occur frequently in CKD. The vast majority of patients are treated with non-operative methods that include lifestyle modification and pharmacotherapy. In summary, hyperuricemia is a risk factor for CKD, and there is strong evidence that it can cause kidney disease by either crystal-dependent or independent mechanisms. There is limited data available on physician’s current practice for the diagnosis and management of hyperuricemia associated with CKD. Therefore, this cross-sectional study is designed to understand the diagnosis and management of hyperuricemia associated with CKD from consultant physicians in India.
If you agree to participate, you will be required to respond to questions of the enclosed questionnaire. We trust you and we are partners in promoting safe and effective drug therapy. In that spirit we hope you will consent to participate in this study.
|
}}){kind=logo}
}})